Mediantechnologies Stock
€2.68
Your prediction
Financial data and news for Median Tech
sharewise wants to provide you with the best news and tools for Median Tech, so we directly link to the best financial data sources.
Financials
News
Median Technologies Reports Full-year 2023 Financial Results and Provides First Quarter 2024 Financial Information
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”) today reported its 2023 consolidated annual financial results, as of December 31
Median Technologies to Participate in the TD Cowen’s 44th Annual Health Care Conference
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) (Paris:ALMDT), will be participating in the TD Cowen’s 44th Annual Health Care Conference, taking place on March 4 –
Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, Austria
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announces today that the Company will be participating and speaking at the premier European radiology conference, the
Median Technologies Reports 2023 Revenue and Summarizes 2024 Strategic Outlook
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announces its 2023 revenue, outlining both its strategic outlook and key milestones for 2024.
Fredrik Brag, Chief
New Date for Median Technologies’ Webcasts: February 1st, 2024
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announced today that Fredrik Brag, CEO and Founder of Median Technologies, will provide a company update on February
Median Technologies to Host Two Webcasts, and Provide a Company Update on January 30, 2024
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) (Paris:ALMDT) announced today that Fredrik Brag, CEO and Founder of Median Technologies, will provide a company
Median Technologies Announces the Drawdown of €8.5m Corresponding to the Final Tranche of the European Investment Bank Loan
Regulatory News:
Median Technologies (Paris:ALMDT) announces that it has received approval from the European Investment Bank to draw down the final tranche of the loan granted on December 18
Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine
Regulatory News:
Median Technologies (Paris:ALMDT) and PASREL-Imagerie, announce today the signing of an agreement to deliver cutting-edge imaging biomarkers for the development of new oncology
Median Technologies to Speak at the IASLC 2023 North America Conference on Lung Cancer (NACLC), Dec. 1-3, Chicago, IL, USA, with two Presentations
Regulatory News:
Median Technologies (Paris:ALMDT) announced today that the Company will be presenting two scientific posters at the 2023 North America Conference on Lung Cancer (NACLC) being
Median Technologies Selected for Support Under the French Government's ETIncelles Program
Regulatory News:
Median Technologies (Paris:ALMDT) is proud to have been chosen to join the ETIncelles scheme, an initiative created by the President of the French Republic, which aims to help
Median Technologies Announces Rebranding of iBiopsy®, Changes Name to eyonis™
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231126347438/en/
Median Technologies (Paris:ALMDT) today unveils a
Median Technologies to Speak at the Radiological Society of North America 2023 Annual Meeting, Nov. 26 - 30, Chicago, IL, USA
Regulatory News:
Median Technologies (ALMDT) announced today that the Company will be speaking and presenting at the world’s largest medical imaging conference, the Radiological Society of North